American Vanguard (AVD) Expected to Release Quarterly Earnings on Monday

American Vanguard (NYSE:AVD) will likely be releasing its Q3 2026 resultson Monday, November 9th. Analysts expect the company to post earnings of ($0.01) per share and revenue of $130.00 million for the quarter. Parties can find conference call details on the company’s upcoming Q3 2026 earnings report for the latest details on the call scheduled for Monday, November 9, 2026 at 9:00 AM ET.

American Vanguard (NYSE:AVD) last released its quarterly earnings results on Monday, August 10th. The basic materials company reported ($0.34) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.43). American Vanguard had a negative net margin of 10.70% and a negative return on equity of 9.05%. The firm had revenue of $116.75 million for the quarter, compared to the consensus estimate of $135.00 million.

American Vanguard Stock Performance

Shares of AVD stock opened at $1.10 on Monday. American Vanguard has a 1 year low of $1.00 and a 1 year high of $5.55. The firm has a market capitalization of $32.45 million, a P/E ratio of -0.58 and a beta of 1.56. The company has a current ratio of 2.47, a quick ratio of 1.40 and a debt-to-equity ratio of 1.46. The firm’s fifty day simple moving average is $1.78 and its 200 day simple moving average is $2.88.

Insider Buying and Selling

In other American Vanguard news, Director Steven D. Macicek bought 19,000 shares of American Vanguard stock in a transaction on Monday, August 17th. The shares were purchased at an average cost of $2.09 per share, with a total value of $39,710.00. Following the acquisition, the director directly owned 99,711 shares of the company’s stock, valued at $208,395.99. The trade was a 23.54% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Keith M. Rosenbloom sold 556,580 shares of the business’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $2.20, for a total transaction of $1,224,476.00. Following the completion of the sale, the director directly owned 15,201 shares in the company, valued at approximately $33,442.20. This represents a 97.34% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 5.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on AVD. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of American Vanguard in a report on Thursday, August 13th. Wall Street Zen downgraded shares of American Vanguard from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the company presently has a consensus rating of “Sell”.

American Vanguard Company Profile

American Vanguard Corporation, doing business primarily through its AMVAC subsidiary, develops, manufactures and markets specialty agricultural products. The company’s portfolio includes crop protection products such as insecticides, herbicides, fungicides, nematicides and soil fumigants designed to help growers manage pests, weeds and plant diseases.

In addition to crop protection, American Vanguard serves the professional and consumer markets for turf and ornamental care, golf course management, pest control and public health.